Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatmentRobert A. McCutcheon, Philip McGuire|Molecular Psychiatry|2023Cited by 684
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary reportJosé Alexandre S. Crippa, Jaime E. C. Hallak, Guilherme Nogueira Derenusson et al.|Journal of Psychopharmacology|2010Cited by 530
Prevention of PsychosisPaolo Fusar‐Poli, Celso Arango, Kim Q. et al.|JAMA Psychiatry|2020Cited by 463
Effects of Cannabidiol (CBD) on Regional Cerebral Blood FlowJosé Alexandre S. Crippa, Geraldo F. Busatto, Antônio Waldo Zuardi et al.|Neuropsychopharmacology|2003Cited by 314
A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational InvestigationAntônio Waldo Zuardi, Francisco Silveira Guimarães, José Alexandre S. Crippa et al.|Current Pharmaceutical Design|2012Cited by 222